Dorsomedial striatal neuroinflammation causes excessive goal-directed action control by disrupting astrocyte function.

Saved in:
Bibliographic Details
Title: Dorsomedial striatal neuroinflammation causes excessive goal-directed action control by disrupting astrocyte function.
Authors: Abiero AR; School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia.; Centre for Neuroscience and Regenerative Medicine, St. Vincent's Centre for Applied Medical Research, St. Vincent's Health Network, Sydney, NSW, Australia.; School of Psychology, Faculty of Science, University of Sydney, Sydney, NSW, Australia., Gladding JM; School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia., Iredale JA; School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, Australia.; Brain Neuromodulation Research Program, Hunter Medical Research Institute, New Lambton Heights, Sydney, NSW, Australia., Drury HR; School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, Australia.; Brain Neuromodulation Research Program, Hunter Medical Research Institute, New Lambton Heights, Sydney, NSW, Australia., Manning EE; School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, Australia.; Brain Neuromodulation Research Program, Hunter Medical Research Institute, New Lambton Heights, Sydney, NSW, Australia., Dayas CV; School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, Australia.; Brain Neuromodulation Research Program, Hunter Medical Research Institute, New Lambton Heights, Sydney, NSW, Australia., Dhungana A; School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia.; Centre for Neuroscience and Regenerative Medicine, St. Vincent's Centre for Applied Medical Research, St. Vincent's Health Network, Sydney, NSW, Australia., Ganesan K; School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia.; Centre for Neuroscience and Regenerative Medicine, St. Vincent's Centre for Applied Medical Research, St. Vincent's Health Network, Sydney, NSW, Australia.; School of Psychology, Faculty of Science, University of Sydney, Sydney, NSW, Australia., Turner K; School of Psychology, University of New South Wales, Sydney, NSW, Australia., Becchi S; Decision Neuroscience Laboratory, School of Psychology, University of New South Wales, Sydney, NSW, Australia.; Teva Pharmaceuticals, Sydney, NSW, Australia., Kendig MD; School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia., Nolan C; Decision Neuroscience Laboratory, School of Psychology, University of New South Wales, Sydney, NSW, Australia., Balleine B; Decision Neuroscience Laboratory, School of Psychology, University of New South Wales, Sydney, NSW, Australia., Castorina A; School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia., Cole L; School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia., Clemens KJ; School of Psychology, University of New South Wales, Sydney, NSW, Australia., Bradfield LA; School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia. laura.bradfield@sydney.edu.au.; Centre for Neuroscience and Regenerative Medicine, St. Vincent's Centre for Applied Medical Research, St. Vincent's Health Network, Sydney, NSW, Australia. laura.bradfield@sydney.edu.au.; School of Psychology, Faculty of Science, University of Sydney, Sydney, NSW, Australia. laura.bradfield@sydney.edu.au.
Source: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology [Neuropsychopharmacology] 2026 Jan; Vol. 51 (2), pp. 486-496. Date of Electronic Publication: 2025 Sep 27.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8904907 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1740-634X (Electronic) Linking ISSN: 0893133X NLM ISO Abbreviation: Neuropsychopharmacology Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1740-634X
DOI:10.1038/s41386-025-02247-4